VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
NTR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
NTRNutrien Ltd.
$69.09$33.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNTRFinancials

Nutrien Ltd. (NTR) Income Statement

30Y historyFree accessUpdated daily

Revenue growth has re-accelerated to 18.5% year-over-year in Q1 2026, but cyclicality drives extreme margin volatility, with gross margins ranging from 25.9% in trough quarters to 35.4% in peak quarters.

Income StatementBalance SheetCash FlowRatios

NTR Income Statement

Annual statement

NTR Income Statement

Nutrien Ltd. (NTR) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue28.2B26.89B25.97B29.06B37.88B27.71B20.91B20.08B19.64B4.55B4.46B6.28B7.12B7.3B7.93B8.71B6.54B3.98B9.45B5.23B3.77B3.85B3.24B2.47B1.93B2.08B2.23B2.06B2.31B2.33B1.4B
Revenue Growth %8.63%3.52%-10.61%-23.3%36.71%32.54%4.1%2.28%331.85%2.04%-29.03%-11.75%-2.6%-7.85%-9.04%33.28%64.43%-57.9%80.48%38.96%-2.09%18.58%31.58%27.85%-7.31%-6.76%8.27%-10.69%-0.78%65.67%63.94%
Cost of Goods Sold19.46B18.54B18.44B20.58B22.46B18.3B15.67B14.58B14.24B3.85B3.63B4.01B4.47B4.51B4.52B4.43B3.85B2.96B4.54B470.2M2.76B2.72B2.56B2.09B1.62B1.67B1.56B1.46B1.51B1.57B920.4M
COGS % of Revenue-68.95%71.01%70.84%59.29%66.05%74.94%72.61%72.54%84.74%81.37%63.86%62.8%61.81%56.98%50.82%58.86%74.49%48.05%8.98%73.4%70.76%79%84.57%84.07%80.43%69.99%70.92%65.32%67.54%65.56%
Gross Profit8.75B8.35B7.53B8.47B15.42B9.41B5.24B5.5B5.39B694M830M2.27B2.65B2.79B3.41B4.29B2.69B1.01B4.91B1.88B1B1.13B681.4M380.4M307.3M407.3M669.8M599.38M800.3M755.1M483.5M
Gross Margin %31.02%31.05%28.99%29.16%40.71%33.95%25.06%27.39%27.46%15.26%18.63%36.14%37.2%38.19%43.02%49.18%41.14%25.51%51.95%35.94%26.6%29.24%21%15.43%15.93%19.57%30.01%29.08%34.68%32.46%34.44%
Gross Profit Growth %-10.85%-11.14%-45.06%63.93%79.6%-4.78%2.04%676.95%-16.39%-63.42%-14.28%-5.13%-18.18%-20.44%59.33%165.13%-79.33%160.87%87.74%-10.93%65.1%79.13%23.79%-24.55%-39.19%11.75%-25.11%5.99%56.17%27.92%
Operating Expenses4.61B4.48B4.58B4.61B4.62B4.63B4.34B3.64B4.98B485M371M516M299M174M391M-20M93M-166.2M272.3M3.18B126.5M232.4M167.1M436M140.4M137.6M399.5M976M387M340M190.6M
OpEx % of Revenue-16.66%17.63%15.88%12.18%16.7%20.74%18.12%25.35%10.67%8.33%8.22%4.2%2.38%4.93%-0.23%1.42%-4.18%2.88%60.67%3.36%6.04%5.15%17.68%7.28%6.61%17.9%47.35%16.77%14.62%13.58%
Selling, General & Admin4.22B4.1B4.17B4.06B4.09B3.82B3.31B3.01B2.88B214M212M239M245M231M219M211M220M183.6M188.4M212.6M158.4M144.5M130.6M96.1M91.7M99.7M111M116.29M116M99.7M60.3M
SG&A % of Revenue-15.27%16.07%13.99%10.8%13.79%15.84%15%14.65%4.71%4.76%3.81%3.44%3.16%2.76%2.42%3.36%4.62%1.99%4.06%4.21%3.76%4.03%3.9%4.75%4.79%4.97%5.64%5.03%4.29%4.3%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses4M374M406M550M523M807M1.03B627M2.1B271M159M277M54M-57M172M-231M-127M-349.8M83.9M2.96B-31.9M87.9M36.5M339.9M48.7M37.9M288.5M859.71M271M240.3M130.3M
Operating Income4.14B3.87B2.95B3.86B10.81B4.78B902M1.86B414M209M459M1.75B2.35B2.62B3.02B4.31B2.6B1.18B4.64B1.59B875.5M892.6M514.3M-55.6M166.9M269.7M270.3M-376.63M413.3M415.1M292.9M
Operating Margin %14.69%14.39%11.36%13.28%28.53%17.25%4.31%9.27%2.11%4.6%10.3%27.92%33%35.81%38.09%49.41%39.72%29.69%49.07%30.35%23.24%23.2%15.85%-2.25%8.65%12.96%12.11%-18.27%17.91%17.85%20.86%
Operating Income Growth %-31.11%-23.55%-64.29%126.08%430.04%-51.56%349.76%98.09%-54.47%-73.82%-25.34%-10.24%-13.35%-29.89%65.81%119.94%-74.52%191.79%81.44%-1.92%73.56%1025%-133.31%-38.12%-0.22%171.77%-191.13%-0.43%41.72%39.83%
EBITDA6.54B6.24B5.29B6.03B12.82B6.73B2.89B3.66B2.01B901M1.15B2.44B3.05B3.28B3.6B4.79B3.05B1.49B4.96B1.88B1.12B1.14B754.3M171.8M386M455.4M457.3M-185.52M604.2M585.1M383M
EBITDA Margin %23.18%23.2%20.37%20.75%33.84%24.29%13.83%18.23%10.22%19.82%25.9%38.83%42.85%44.93%45.38%55.02%46.58%37.54%52.53%35.91%29.68%29.5%23.25%6.97%20.01%21.89%20.49%-9%26.18%25.16%27.28%
EBITDA Growth %27.77%17.92%-12.26%-52.98%90.45%132.86%-21.03%82.5%122.64%-21.92%-52.67%-20.04%-7.1%-8.76%-24.98%57.42%104.03%-69.92%164%68.15%-1.51%50.47%339.06%-55.49%-15.24%-0.42%346.5%-130.7%3.26%52.77%36.57%
D&A (Non-Cash Add-back)2.39B2.37B2.34B2.17B2.01B1.95B1.99B1.8B1.59B692M695M685M701M666M578M489M449M312.1M327.5M291.3M242.4M242.4M240M227.4M219.1M185.7M187M191.11M190.9M170M90.1M
EBIT3.91B3.78B1.87B2.72B10.77B4.63B903M1.87B431M211M462M1.75B2.35B2.62B3.02B4.31B2.6B1.19B4.65B1.62B875.5M892.6M517.9M260.5M172.4M256M294.6M214.89M413.3M415.1M292.9M
Net Interest Income-744M-678M-634.02M-768.85M-505.16M-466.86M-520M-554M-538M-238M-216M-192M-184M-144M-114M-159M-121M-120.9M-62.8M-68.7M00000000000
Interest Income051M26.66M35.64M24.01M7.93M1M5M17M2M3M2M1M3M4M8M8M10.5M17.7M29.8M00000000000
Interest Expense744M729M660.68M804.49M529.17M474.79M521M559M555M240M219M194M185M147M118M167M129M131.4M80.5M98.5M00000000000
Other Income/Expense-981M-820M-1.81B-1.91B-563M-613M-520M-554M-538M-238M-216M-192M-184M-144M-114M-159M-121M-120.9M-62.8M-68.7M-85.6M-82.3M-84M-91.3M-83.1M-80.3M-5.1M-27.9M-34.8M-48.9M-40.2M
Pretax Income3.16B3.05B1.14B1.95B10.25B4.17B382M1.31B-124M-29M243M1.56B2.16B2.47B2.9B4.15B2.48B1.06B4.57B1.52B789.9M810.3M430.3M-146.9M83.8M189.4M265.2M-404.52M378.5M366.2M252.7M
Pretax Margin %11.21%11.34%4.37%6.72%27.05%15.04%1.83%6.51%-0.63%-0.64%5.45%24.86%30.41%33.84%36.65%47.58%37.87%26.65%48.4%29.04%20.97%21.06%13.26%-5.96%4.34%9.1%11.88%-19.63%16.4%15.74%18%
Income Tax753M752M436M670M2.56B989M-77M316M-93M-183M44M446M628M687M826M1.07B701M79.2M1.08B416.2M158.1M267.4M131.7M-20.6M30.2M68.2M67.2M7.47M117.5M69.1M43.7M
Effective Tax Rate %23.81%24.66%38.38%34.32%24.98%23.73%-20.16%24.16%75%631.03%18.11%28.57%29.02%27.79%28.43%25.71%28.31%7.47%23.56%27.39%20.02%33%30.61%14.02%36.04%36.01%25.34%-1.85%31.04%18.87%17.29%
Net Income2.38B2.27B674M1.26B7.66B3.15B459M992M3.57B327M336M1.27B1.54B1.78B2.08B3.08B1.81B987.8M3.5B1.1B631.8M542.9M298.6M-126.3M53.6M121.2M198M-411.99M261M297.1M209M
Net Margin %8.44%8.43%2.6%4.33%20.22%11.38%2.2%4.94%18.2%7.19%7.54%20.23%21.59%24.44%26.23%35.35%27.62%24.84%37%21.08%16.77%14.11%9.2%-5.12%2.78%5.82%8.87%-19.99%11.31%12.77%14.89%
Net Income Growth %74.61%236.35%-46.42%-83.58%142.94%586.93%-53.73%-72.24%992.66%-2.68%-73.54%-17.32%-13.95%-14.14%-32.52%70.58%82.85%-71.74%216.71%74.68%16.38%81.82%336.42%-335.63%-55.78%-38.79%148.06%-257.85%-12.15%42.15%31.03%
Net Income (Continuing)2.41B2.3B700M1.28B7.69B3.18B459M992M-31M154M199M1.11B1.54B1.78B2.08B3.08B1.77B980.7M3.5B1.1B631.8M542.9M298.6M-126.3M53.6M121.2M198M-411.99M261M297.1M209M
Discontinued Operations0000000000000000000000000000000
Minority Interest36M41.92M35M45M45M47M38M000000000000000000000000
EPS (Diluted)4.964.741.362.5313.625.470.851.745.720.981.003.804.555.105.938.784.882.709.182.831.651.360.75-0.340.140.320.52-1.050.670.790.64
EPS Growth %77.14%248.53%-46.25%-81.42%148.99%543.53%-51.15%-69.58%483.67%-2%-73.68%-16.48%-10.78%-14%-32.46%79.92%80.74%-70.59%224.38%71.52%21.32%81.33%320.59%-342.86%-56.25%-38.46%149.52%-256.72%-15.19%23.44%25.49%
EPS (Basic)-4.741.362.5313.665.490.851.745.760.981.003.804.585.156.059.005.002.789.482.921.691.390.77-0.340.140.320.52-1.060.670.790.64
Diluted Shares Outstanding479.82M486.52M494.37M496.99M540.01M571.29M569.69M583.1M624.9M336.13M335.78M334.94M337.82M349.59M350.36M350.65M364.44M364.73M380.95M389.17M382.43M400.28M398.66M376.06M377.05M376.12M377.73M391.26M390.17M376.98M328.17M
Basic Shares Outstanding479.6M486.33M494.37M496.38M538.48M569.66M569.66M582.27M620M336.03M335.57M333.66M335.24M345.84M344.01M342.27M354.55M354.7M354.24M378.77M374.26M391.24M388.68M376.06M374.93M373.9M377.73M390.31M389.88M376.98M328.17M
Dividend Payout Ratio-47.62%157.27%82.03%13.46%33.14%224.4%103.02%26.64%100.92%240.77%94.8%74.28%55.85%22.46%6.75%6.59%11.83%3.51%8.48%9.64%12.05%18.79%-97.01%42.82%26.21%-19.81%18.61%23.06%

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Sharp seasonal profitability swings

Revenue Growth Recovery in Early 2026

Nutrien's revenue growth has shifted from contraction to expansion, with Q1 2026 posting an 18.5% year-over-year increase, though this follows a period of significant decline and volatile quarterly performance.

The company has moved from a string of negative year-over-year revenue growth quarters through 2024 and early 2025 to positive growth in the most recent periods. This rebound suggests a potential cyclical upturn in the agricultural inputs market, but the high volatility between quarters, such as the swing from -5.4% in Q1 2025 to +18.5% in Q1 2026, indicates growth durability remains unproven and may be driven by temporary factors like inventory restocking rather than sustained demand increases.

Cyclicality Drives Wide Margin Swings

Gross margins demonstrate pronounced seasonality, expanding to 35.4% in Q4 2025 from a low of 25.9% in Q1 2025, reflecting the commodity-driven nature of the business.

The structural gross margin level appears to sit in the high-20% to low-30% range, but actual performance is dominated by seasonal patterns, likely tied to planting and application cycles. When compared to peers, Nutrien's recent margins (e.g., 30.1% in Q2 2026) are materially higher than Mosaic's 15.1% but lower than CF Industries' 38.5%, suggesting its position in the value chain provides moderate, but not leading, pricing power. Investors should monitor whether recent margin expansions are sustainable or simply a function of favorable quarterly timing.

Operating Leverage Activated in Peak Quarter

Operating leverage was strongly demonstrated in Q2 2026, where operating income scaled to $2.0B on $10.8B in revenue, representing an 18.4% margin, a significant improvement from the 8.4% margin in Q1 2026.

The quarter-over-quarter expansion in operating margin from 8.4% to 18.4% indicates that Nutrien's cost structure allows profitability to scale rapidly with revenue growth. However, this leverage appears cyclical rather than structural, as the high fixed-cost base is more efficient during peak sales periods but compresses sharply in off-peak quarters like Q1. This pattern implies the business has limited control over earnings volatility, which is largely dictated by external market conditions and seasonal demand.

Potential Unsustainability of EPS Recovery

Despite a recent EPS recovery, the year-over-year growth rates are heavily distorted by extremely low prior-year comparables, such as the 11.1% growth in Q1 2026 versus a -93.0% decline in Q1 2025.

The reported EPS growth figures, while positive, are not indicative of a stable earnings trajectory when viewed against the volatile historical base. For instance, Q3 2025's 24.8% EPS growth followed a -75.7% drop in Q3 2024. This volatility suggests that the recent improvement may reflect a cyclical rebound from a trough rather than a permanent improvement in business fundamentals. Short-sellers would focus on whether the current profitability level can be maintained through a full agricultural cycle without significant price compression.

SG&A Shows Partial Operating Discipline

SG&A expenses have been held relatively stable between $956M and $1.2B per quarter, even as revenue fluctuates significantly, suggesting some degree of fixed-cost management.

The consistency of SG&A expenses during periods of both high and low revenue indicates a baseline level of operational discipline. However, the absolute level of these expenses, which are roughly 10-20% of revenue depending on the quarter, remains a significant drag on profitability during off-peak periods. The lack of any material SG&A reduction during the revenue downturns of 2024 suggests limited flexibility in discretionary spending, which may hamper margin recovery if top-line growth stalls again.

NTR — Frequently Asked Questions

Quick answers to the most common questions about buying NTR stock.

What was Nutrien Ltd.'s (NTR) revenue in 2025?

For fiscal year 2025, Nutrien Ltd. (NTR) reported total revenue of $26.89B. This represents a 1815.0% increase compared to $1.40B in 1996.

Is Nutrien Ltd. (NTR) profitable?

Nutrien Ltd. (NTR) is profitable, generating $2.27B in net income for the fiscal year ending 2025 with a net profit margin of 8.4%.

What is Nutrien Ltd.'s operating profit margin?

Nutrien Ltd. (NTR) reported an operating income of $3.87B, resulting in an operating profit margin of 14.4%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Nutrien Ltd.'s gross profit and gross margin?

Nutrien Ltd. (NTR) generated $8.35B in gross profit for the year, representing a gross profit margin of 31.0%. This demonstrates the company's core pricing power and production efficiency.